Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nigro

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
JAMA|May 1, 1996
Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophiesL Politano, V Nigro, G Nigro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Left ventricular function and perfusion in Becker's muscular dystrophyL Mansi, L Pace, L Politano, et al.
Giornale Italiano Di Cardiologia|July 9, 1999
[Idiopathic left fascicular ventricular tachycardia: the evidence for a "bystander" bundle of His participation]V Ducceschi, G Nigro, B Sarubbi, et al.
Archives of Virology. Supplementum|January 1, 1993
Multiple viral infections in HIV-infected children with chronically-evolving hepatitisG Nigro, G Taliani, A Krzysztofiak, et al.
Archives of Virology. Supplementum|January 1, 1992
Hepatitis in children with thalassemia majorG Nigro, G Taliani, U Bartmann, et al.
Cell Death & Disease|March 4, 2011
Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivoL Lembo-Fazio, G Nigro, G Noël, et al.
Human Molecular Genetics|October 1, 1995
SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin functionV Nigro, P Bruni, A Ciccodicola, et al.
Neuromuscular Disorders : NMD|September 1, 2004
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocolsW D Biggar, L Politano, V A Harris, et al.
Journal of Endocrinological Investigation|October 11, 2020
Sperm cryopreservation during the SARS-CoV-2 pandemicD Paoli, F Pallotti, G Nigro, et al.
European Review for Medical and Pharmacological Sciences|November 5, 2015
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registryV Russo, V Bianchi, C Cavallaro, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
JAMA|May 1, 1996
Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophiesL Politano, V Nigro, G Nigro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Left ventricular function and perfusion in Becker's muscular dystrophyL Mansi, L Pace, L Politano, et al.
Giornale Italiano Di Cardiologia|July 9, 1999
[Idiopathic left fascicular ventricular tachycardia: the evidence for a "bystander" bundle of His participation]V Ducceschi, G Nigro, B Sarubbi, et al.
Archives of Virology. Supplementum|January 1, 1993
Multiple viral infections in HIV-infected children with chronically-evolving hepatitisG Nigro, G Taliani, A Krzysztofiak, et al.
Archives of Virology. Supplementum|January 1, 1992
Hepatitis in children with thalassemia majorG Nigro, G Taliani, U Bartmann, et al.
Cell Death & Disease|March 4, 2011
Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivoL Lembo-Fazio, G Nigro, G Noël, et al.
Human Molecular Genetics|October 1, 1995
SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin functionV Nigro, P Bruni, A Ciccodicola, et al.
Neuromuscular Disorders : NMD|September 1, 2004
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocolsW D Biggar, L Politano, V A Harris, et al.
Journal of Endocrinological Investigation|October 11, 2020
Sperm cryopreservation during the SARS-CoV-2 pandemicD Paoli, F Pallotti, G Nigro, et al.
European Review for Medical and Pharmacological Sciences|November 5, 2015
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registryV Russo, V Bianchi, C Cavallaro, et al.
Pageof 16